Nicotinic receptor losses in dementia with Lewy bodies: Comparisons with Alzheimer's disease

Neurobiology of Aging

Volumn 21, Issue 5, 2000, Pages 741-746

  Reid, Richard T ^a   Sabbagh, Marwan N ^b,c   CoreyBloom, Jody ^b,c   Tiraboschi, Pietro ^d   Thal, Leon J ^b,c  

^a Banck Clinical Research Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

bungarotoxin; Alzheimer's disease; Epibatidine; Lewy body disease; Nicotinic acetylcholine receptor

Indexed keywords

BUNGAROTOXIN; CHOLINE ACETYLTRANSFERASE; EPIBATIDINE; NICOTINIC RECEPTOR; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC NERVE CELL; CHOLINERGIC SYNAPSE; CONTROLLED STUDY; DEMENTIA; FRONTAL CORTEX; HUMAN; HUMAN CELL; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BICYCLO COMPOUNDS, HETEROCYCLIC; BUNGAROTOXINS; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; COMPARATIVE STUDY; HUMAN; IODINE RADIOISOTOPES; LEWY BODY DISEASE; NEURONS; NICOTINIC AGONISTS; PYRIDINES; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRITIUM;

EID: 0034282064     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00168-8     Document Type: Article

References (41)

1. Nicotinic acetylcholine receptors on hippocampal neurons; distribution on the neuronal surface and modulation of receptor activity
2. A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain
3. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases
4. Cognitive profiles of autopsy-confirmed Lewy body variant s pure Alzheimer's disease
5. Post mortem stability of alpha-bungarotoxin binding sites in mouse and human brain
6. 3H]Nicotine binding in human cerebral cortex; comparison between Alzheimer's disease and the normal
7. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase and acetylcholinesterase activities
8. Evidence in post mortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
9. Nicotine acetylcholine receptors in human cortex; aging and Alzheimer's disease
10. Frontal cortical synaptophysin in Lewy body diseases; relation to Alzheimer's disease and dementia
11. Neocortical morphometry and cholinergic neurochemistry in Pick's disease
12. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease
13. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa
14. Diagnosis of Alzheimer's disease
15. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients
16. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies
17. Further investigation of a chromosome 15 locus in schizophrenia; analysis of affected sibpairs from the NIMH Genetics Initiative
18. Nicotinic binding sites in rat and mouse brain; comparison of acetylcholine, nicotine and α-bungarotoxin
19. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB); report of the consortium on DLB international workshop
20. Clinical diagnosis of Alzheimer's disease
21. The consortium to establish a registry for Alzheimer's disease (CERAD). ; Part II: standardization of the neuropathological assessment of Alzheimer's disease
22. Nicotinic and muscarinic subtypes in the human brain; changes with aging and dementia
23. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
24. Evidence of a Monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia
25. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease; possible index of early neuropathology
26. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease
27. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases
28. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types
29. Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats
30. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease
31. Nicotinic receptors in the development and modulation of CNS synapses
32. Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer's disease
33. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease
34. The diversity of neuronal nicotinic acetylcholine receptors
35. Dementia with Lewy bodies versus pure Alzheimers disease; differences in cognition, neuropathology, cholinergic dysfunction and synapse density
36. Immuno- and cytochemical localization of cortical nicotinic cholinoceptors in rat and man
37. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains
38. Selective α-7 nicotinic agonists normalize inhibition of auditory response in DBA mice
39. Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains
40. Presynaptic nicotinic acetylcholine receptors in the brain